Overview
Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)
Description
The objective of this study is to evaluate the administration of the Travoprost intracameral implant using the updated inserter (Model G2-TRIO)
Eligibility
Inclusion Criteria:
- Diagnosis of Open-angle glaucoma
- 18 years of age or older
Exclusion Criteria:
- Subject who is breast-feeding or pregnant